NDAORALTABLET, EXTENDED RELEASE
Approved
Dec 1998
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
3
Mechanism of Action
CLINICAL PHARMACOLOGY Oxybutynin chloride exerts a direct antispasmodic effect on smooth muscle and inhibits the muscarinic action of acetylcholine on smooth muscle. Oxybutynin chloride exhibits only one-fifth of the anticholinergic activity of atropine on the rabbit detrusor muscle, but four to…
Clinical Trials (3)
Oxybutynin Chloride in Managing Hot Flashes
Started Dec 2016
150 enrolled
Breast CarcinomaDuctal Breast Carcinoma In SituHot Flashes+2 more
An Efficacy and Safety Study of Oxybutynin Chloride Oral Osmotic Therapeutic System (OROS) in Korean Overactive Bladder Participants
Started Sep 2007
345 enrolled
Urinary Bladder, Overactive
The Effect of Extended-Release Oxybutynin Chloride on Vasomotor Symptoms in Healthy Post-Menopausal Women
Started Apr 2004
148 enrolled
MenopauseHot Flashes